Does GOLD AU-198 Cause Malignant neoplasm progression? 14 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Malignant neoplasm progression have been filed in association with GOLD AU-198. This represents 15.4% of all adverse event reports for GOLD AU-198.
14
Reports of Malignant neoplasm progression with GOLD AU-198
15.4%
of all GOLD AU-198 reports
0
Deaths
0
Hospitalizations
How Dangerous Is Malignant neoplasm progression From GOLD AU-198?
Of the 14 reports.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLD AU-198. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does GOLD AU-198 Cause?
Treatment failure (69)
Drug ineffective (62)
Infection (62)
Rheumatoid arthritis (62)
Rash (58)
Pain (46)
Musculoskeletal stiffness (45)
Joint stiffness (43)
Sleep disorder (41)
Nausea (40)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)